Cargando…
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers
Despite recent advances in diagnosis and treatment of lung cancers, the 5-year survival rate remains unsatisfactory, which necessitates the identification of novel factors that associates with disease progression and malignant degree for improving diagnostic and therapeutic strategies. Recent progre...
Autores principales: | Baghdadi, Muhammad, Endo, Hiraku, Takano, Atsushi, Ishikawa, Kozo, Kameda, Yosuke, Wada, Haruka, Miyagi, Yohei, Yokose, Tomoyuki, Ito, Hiroyuki, Nakayama, Haruhiko, Daigo, Yataro, Suzuki, Nao, Seino, Ken-ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765132/ https://www.ncbi.nlm.nih.gov/pubmed/29323162 http://dx.doi.org/10.1038/s41598-017-18796-8 |
Ejemplares similares
-
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
por: Han, Nanumi, et al.
Publicado: (2018) -
Enhanced expression of IL-34 in an inflammatory cyst of the submandibular gland: a case report
por: Baghdadi, Muhammad, et al.
Publicado: (2018) -
Proteome analysis of CD5-positive diffuse large B cell lymphoma FFPE tissue reveals downregulation of DDX3X, DNAJB1, and B cell receptor signaling pathway proteins including BTK and Immunoglobulins
por: Hiratsuka, Takuya, et al.
Publicado: (2023) -
CD26 expression is attenuated by TGF‐β and SDF‐1 autocrine signaling on stromal myofibroblasts in human breast cancers
por: Mezawa, Yoshihiro, et al.
Publicado: (2019) -
Glutamine deficiency drives transforming growth factor‐β signaling activation that gives rise to myofibroblastic carcinoma‐associated fibroblasts
por: Mezawa, Yoshihiro, et al.
Publicado: (2023)